Gene expression and the biological phenotype of papillary thyroid carcinomas

[1]  David E. Misek,et al.  Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis , 2005, Oncogene.

[2]  S. Keyse,et al.  Specific Inactivation and Nuclear Anchoring of Extracellular Signal-Regulated Kinase 2 by the Inducible Dual-Specificity Protein Phosphatase DUSP5 , 2005, Molecular and Cellular Biology.

[3]  B. Loriod,et al.  Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma , 2005, Oncogene.

[4]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[5]  I. Ekiel,et al.  Metastasis-associated Protein S100A4 Induces Angiogenesis through Interaction with Annexin II and Accelerated Plasmin Formation* , 2005, Journal of Biological Chemistry.

[6]  M. Kruhøffer,et al.  The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. , 2005, The Journal of clinical investigation.

[7]  O. Gimm Thyroid cancer. , 2001, Cancer letters.

[8]  Y. Nikiforov,et al.  Alterations of the BRAF gene in thyroid tumors , 2005, Endocrine pathology.

[9]  L. Martiny,et al.  Human thyroid carcinoma cell invasion is controlled by the low density lipoprotein receptor-related protein-mediated clearance of urokinase plasminogen activator. , 2006, The international journal of biochemistry & cell biology.

[10]  Ming-Ming Zhou,et al.  Structure and regulation of MAPK phosphatases. , 2004, Cellular signalling.

[11]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[12]  P. Friedl Prespecification and plasticity: shifting mechanisms of cell migration. , 2004, Current opinion in cell biology.

[13]  Karin Milde-Langosch,et al.  The Fos family of transcription factors and their role in tumourigenesis. , 2005, European journal of cancer.

[14]  V. Detours,et al.  Gene expression in thyroid autonomous adenomas provides insight into their physiopathology , 2005, Oncogene.

[15]  P. W. Janes,et al.  Analysis of Grb7 Recruitment by Heregulin-activated erbB Receptors Reveals a Novel Target Selectivity for erbB3* , 1998, The Journal of Biological Chemistry.

[16]  Krzysztof Fujarewicz,et al.  Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. , 2005, Cancer research.

[17]  R. Kurten,et al.  Enhanced Degradation of EGF Receptors by a Sorting Nexin, SNX1 , 1996, Science.

[18]  William Stafford Noble,et al.  The effect of replication on gene expression microarray experiments , 2003, Bioinform..

[19]  L. Akslen,et al.  Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. , 1996, Cancer research.

[20]  Manuela Gariboldi,et al.  Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Zou,et al.  S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma , 2005, British Journal of Cancer.

[22]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[23]  V. Detours,et al.  Absence of a specific radiation signature in post-Chernobyl thyroid cancers , 2005, British Journal of Cancer.

[24]  L. Akslen,et al.  Gene expression in poorly differentiated papillary thyroid carcinomas. , 2006, Thyroid : official journal of the American Thyroid Association.

[25]  L. Lund,et al.  Plasminogen activation and cancer , 2005, Thrombosis and Haemostasis.

[26]  S. Asa,et al.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.

[27]  M. Pierotti,et al.  RET and NTRK1 proto‐oncogenes in human diseases , 2003, Journal of cellular physiology.

[28]  Huiling He,et al.  Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion , 2007, Proceedings of the National Academy of Sciences.

[29]  Pier Paolo Di Fiore,et al.  The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5 , 2000, Nature.

[30]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Powell,et al.  A Thyroid Tumor-Specific Antigen Formed by the Fusion of Two Self Proteins1 , 2003, The Journal of Immunology.

[32]  C Eng,et al.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Akslen,et al.  Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas , 2000, International journal of cancer.

[34]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[35]  N. Mitsiades,et al.  Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis. , 2006, The Journal of clinical endocrinology and metabolism.

[36]  R. DeLellis Pathology and genetics of tumours of endocrine organs , 2004 .

[37]  S. Wiseman,et al.  TIMP1 and SERPIN‐A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma , 2004, Head & neck.

[38]  H. Nagaraja,et al.  Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors , 2005, Modern Pathology.

[39]  Se Hoon Kim,et al.  Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p-JNK and p-AKT) in papillary thyroid carcinomas. , 2004, Yonsei medical journal.

[40]  Q. Duh,et al.  Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo. , 1994, The Journal of clinical endocrinology and metabolism.

[41]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[42]  E. Skrzydlewska,et al.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. , 2005, World journal of gastroenterology.